Al Aqar Healthcare Stock EBITDA
| 5116 Stock | 1.30 0.04 2.99% |
Al Aqar Healthcare fundamentals help investors to digest information that contributes to Al Aqar's financial success or failures. It also enables traders to predict the movement of 5116 Stock. The fundamental analysis module provides a way to measure Al Aqar's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Al Aqar stock.
5116 |
Al Aqar Healthcare Company EBITDA Analysis
Al Aqar's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Al Aqar EBITDA | 99.22 M |
Most of Al Aqar's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Al Aqar Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Al Aqar Healthcare reported earnings before interest,tax, depreciation and amortization of 99.22 M. This is 86.64% lower than that of the Real Estate sector and significantly higher than that of the Residential & Commercial REITs industry. The ebitda for all Malaysia stocks is 97.45% higher than that of the company.
5116 EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Al Aqar's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Al Aqar could also be used in its relative valuation, which is a method of valuing Al Aqar by comparing valuation metrics of similar companies.Al Aqar is currently under evaluation in ebitda category among its peers.
5116 Fundamentals
| Return On Equity | 7.98 | |||
| Current Valuation | 1.52 B | |||
| Price To Book | 0.95 X | |||
| Price To Sales | 8.38 X | |||
| Revenue | 114.07 M | |||
| EBITDA | 99.22 M | |||
| Net Income | 72.78 M | |||
| Total Debt | 683.88 M | |||
| Cash Flow From Operations | 88.58 M | |||
| Market Capitalization | 897.9 M | |||
| Total Asset | 1.66 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 1.66 B | |||
| Last Dividend Paid | 0.077 |
About Al Aqar Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Al Aqar Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Al Aqar using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Al Aqar Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in 5116 Stock
Al Aqar financial ratios help investors to determine whether 5116 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 5116 with respect to the benefits of owning Al Aqar security.